| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |